Second line chemotherapy after first line irinotecan, oxaliplatin and 5-FU/LV (FOLFOXIRI) in metastatic colorectal cancer (MCRC) patients (pts) No significant financial relationships to disclose. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback